Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Early Detect is a diagnostic healthcare company that specializes in the development, manufacturing, and distribution of rapid in vitro diagnostic (IVD) tests for both consumer and professional use. Founded in 1996, the company provides a wide range of home testing kits designed for privacy and ease of use, covering areas such as pregnancy, fertility, and infectious diseases. Its product portfolio includes high-accuracy tests for HIV, H. pylori, and hormonal indicators like FSH for menopause. Early Detect aims to lead the point-of-care market by offering affordable, lab-quality results in non-clinical settings. The company has also engaged in research for specialized diagnostics, including avian influenza vaccines and tests for global health initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Early Detect.